Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2013; 19(39): 6630-6636
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6630
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6630
Figure 1 Overall survival (A) and progression-free survival (B) according to increased ABCG2 mRNA expression times (intermediate or high vs low tertiles).
OS: Overall survival; PFS: Progression-free survival.
- Citation: Zhang Q, Li K, Xu JH, Zhao CG, Gao Q, Wu B, Liu XY. Role of ABCG2 expression driven by cisplatin in platinum-containing chemotherapy for gastric cancer. World J Gastroenterol 2013; 19(39): 6630-6636
- URL: https://www.wjgnet.com/1007-9327/full/v19/i39/6630.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i39.6630